Dermatomyositis: severe acute respiratory syndrome coronavirus 2, an initiator or a trigger?

Autor:	Suparna, Madivalara, Patil, Deena, Shivaswamy, Kanakapura, Sumathy, Tharayil
Předmět:	METHYLPREDNISOLONE COVID-19 DERMATOMYOSITIS COVID-19 vaccines POST-acute COVID-19 syndrome MYCOPHENOLIC acid CUTANEOUS manifestations of general diseases TREATMENT effectiveness HYDROXYCHLOROQUINE DISEASE complications THERAPEUTICS
Zdroj:	Journal of the Egyptian Women's Dermatologic Society; Jan-Apr2023, Vol. 20 Issue 1, p52-56, 5p
Abstrakt:	Dermatomyositis is an immune-mediated inflammatory myopathy. In adults, the common triggering factors for its onset include viral infections, malignancy, and drugs. The clinical manifestation of these group of disorders may be cutaneous, neurological, pulmonary, or a combination of all. The cutaneous manifestations are helpful in the early clinical diagnosis. The detection of myositis-specific autoantibodies serves as specific biomarkers for the diagnosis and helps in predicting the prognosis. We are presenting two cases of dermatomyositis, temporally related to the severe acute respiratory syndrome coronavirus 2 infection and vaccination. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu